The synthesis and evaluation of triazolopyrimidines as anti-tubercular agents

Edison S. Zuniga, Aaron Korkegian, Steven F. Mullen, Erik J. Hembre, Paul L. Ornstein, Guillermo S. Cortez, Kallolmay Biswas, Naresh Kumar, Jeffrey W. Cramer, Thierry Masquelin,

Bioorganic & Medicinal Chemistry · 2017 · 55 citations · 14 references

DOIFull text

Open access

Concepts

Abstract

We identified a di-substituted triazolopyrimidine with anti-tubercular activity against Mycobacterium tuberculosis. Three segments of the scaffold were examined rationally to establish a structure-activity relationship with the goal of improving potency and maintaining good physicochemical properties. A number of compounds displayed sub-micromolar activity against Mycobacterium tuberculosis with no cytotoxicity against eukaryotic cells. Non-substituted aromatic rings at C5 and a two-carbon chain connecting a terminal aromatic at C7 were preferred features; the presence of NH at C7 and a lack of substituent at C2 were essential for potency. We identified compounds with acceptable metabolic stability in rodent and human liver microsomes. Our findings suggest that the easily-synthesized triazolopyrimidines are a promising class of potent anti-tubercular agents and warrant further investigation in our search for new drugs to fight tuberculosis.

References

14